GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
40,950
-250 (-0.61%)
At close: Feb 6, 2026
114.51%
Market Cap1.73T +151.1%
Revenue (ttm)73.64B +17.4%
Net Income-59.72B
EPS-1,470.58
Shares Out42.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume311,519
Average Volume536,564
Open38,500
Previous Close41,200
Day's Range38,300 - 43,700
52-Week Range19,230 - 72,700
Beta1.35
RSI64.24
Earnings DateAug 14, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1998
Employees 182
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial Statements